129 related articles for article (PubMed ID: 2652496)
1. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial.
Morales JM; Andrés A; Prieto C; Ortuño B; Estenoz J; Dorado C; Arenas J; Ruilope LM; Fernández-Cruz L; Rodicio JL
Transplant Proc; 1989 Feb; 21(1 Pt 2):1537-9. PubMed ID: 2652496
[No Abstract] [Full Text] [Related]
2. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study.
Morales JM; Andrés A; Alvarez C; Prieto C; Ortuño B; Ortuño T; Paternina ER; Hernandez Poblete G; Praga M; Ruilope LM
Transplant Proc; 1990 Aug; 22(4):1733-5. PubMed ID: 2389446
[No Abstract] [Full Text] [Related]
3. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
4. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
5. Triple therapy improves the survival of cadaver renal allografts affected by acute tubular necrosis.
Bakran A; Johnson RW; Dyer PA; Mallick NP; Gokal R
Transplant Proc; 1989 Feb; 21(1 Pt 2):1278-9. PubMed ID: 2652423
[No Abstract] [Full Text] [Related]
6. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
[No Abstract] [Full Text] [Related]
7. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
8. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
[No Abstract] [Full Text] [Related]
9. Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels.
Alcaraz A; Oppenheimer F; Talbot-Wright R; Fernández-Cruz L; Mañalich M; García-Pagés E; Cetina A; Vendrell JR; Carretero P
Transplant Proc; 1991 Oct; 23(5):2383-4. PubMed ID: 1926395
[No Abstract] [Full Text] [Related]
10. Japanese Multicenter Trial of Cyclosporine in Renal Transplantation: overall results and analysis of the factors influencing graft survival rate.
Ochiai T; Toma H; Takagi H; Oka T; Ishibashi M; Kashiwabara H; Fukao K; Ota K; Hashimoto I; Sonoda T
Transplant Proc; 1987 Apr; 19(2):2961-6. PubMed ID: 3551242
[No Abstract] [Full Text] [Related]
11. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
12. The effect of acute tubular necrosis on cyclosporine-treated kidney transplants.
Paramasivan ON; Griffin PJ; Ross WB; Salaman JR
Transplant Proc; 1987 Feb; 19(1 Pt 3):2085. PubMed ID: 3274474
[No Abstract] [Full Text] [Related]
13. An approach to the renal transplant recipient with persistent one-month graft nonfunction.
Gritsch HA; Koyle MA; Ward HJ; Sender MB; Rajfer J; Cohen AH; Glassock RJ; Mickey MR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1527-8. PubMed ID: 2652492
[No Abstract] [Full Text] [Related]
14. Preservation effect on oligo-anuria in the cyclosporine era: a prospective trial with 26 paired cadaveric renal allografts.
Mendez R; Mendez RG; Koussa N; Cats S; Bogaard TP; Khetan U
Transplant Proc; 1987 Feb; 19(1 Pt 3):2047-50. PubMed ID: 3547908
[No Abstract] [Full Text] [Related]
15. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
[No Abstract] [Full Text] [Related]
16. Baseline biopsies define cyclosporine nephrotoxicity.
Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
[No Abstract] [Full Text] [Related]
17. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
[No Abstract] [Full Text] [Related]
18. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
[No Abstract] [Full Text] [Related]
19. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
Santelli G; Hiesse C; Schovaert D; Fassi-Fihri S; Lantz O; Bensadoun H; Benoit G; Charpentier B; Martin E; Fries D
Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
[No Abstract] [Full Text] [Related]
20. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
